PeptideDB

5-OH-HxMF

CAS: 1176-88-1 F: C21H22O9 W: 418.39

5-OH-HxMF is a hydroxylated polymethoxyflavone that has anti-inflammatory, anticancer, neurotrophic and neuroprotective
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity 5-OH-HxMF is a hydroxylated polymethoxyflavone that has anti-inflammatory, anticancer, neurotrophic and neuroprotective activities[1][2][3].
Invitro 5-OH-HxMF(5-20 µM;48 小时)有效诱导 PC12 神经突生长,并伴有神经元分化标记蛋白生长相关蛋白 43(GAP-43)的表达[1] 。 5-OH-HxMF(20 µM;0-120 分钟)导致环 AMP 反应元件结合蛋白 (CREB) 磷酸化、c-fos 基因表达和 CRE 介导的转录增强[1]。 5-OH-HxMF 显着减少一氧化氮和前列腺素 E2 的产生,并下调脂多糖 (LPS) 刺激的 RAW 264.7 细胞中的诱导型一氧化氮合酶 (iNOS) 和 COX-2 表达。5-OH-HxMF 抑制促炎细胞因子的释放,例如肿瘤坏死因子-α 和 IL-1β,并降低转录水平。5-OH-HxMF 显着抑制 LPS 诱导的 NF-κB 从细胞质向细胞核的易位,这与抑制性 IκBα 降解的消除和随后核 p65 水平的降低有关[2]。5-OH-HxMF 在人白血病细胞中抑制细胞生长并诱导细胞凋亡[3]。PC12 cells10 µM, 20 µM24 hPromoted GAP-43 expression in PC12 cells.PC12 cells20 µM0 min, 30 min, 60 min or 120 minStimulated phosphorylation of CREB in PC12 cells. Cell Viability Assay[1] Cell Line:
In Vivo 5-OH-HxMF(局部处理;每周两次;20 周;200 μL 丙酮中 1 和 3 μmol)是一种有效的抗肿瘤剂,其抑制作用是通过下调炎症 iNOS 和 COX-2 基因表达在小鼠皮肤中[3]。 Animal Model:
Name 5-OH-HxMF
CAS 1176-88-1
Formula C21H22O9
Molar Mass 418.39
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Hui-Chi Lai, et al. Neurotrophic effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone: promotion of neurite outgrowth via cAMP/PKA/CREB pathway in PC12 cells. PLoS One. 2011;6(11):e28280. [2]. Min Jeong Kim, et al. Anti-inflammatory effects of 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone via NF-κB inactivation in lipopolysaccharide-stimulated RAW 264.7 macrophage. Mol Med Rep. 2014 Apr;9(4):1197-203. [3]. Ching-Shu Lai, et al. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis. 2007 Dec;28(12):2581-8.